Vertex Pharmaceuticals Inc

NASDAQ:VRTXUnited States

Vertex Pharmaceuticals Incorporated (VRTX) is currently at $468.98, up $13.64 or 3% --Would be new all-time high (Based on available data back to July 24, 1991) --On pace for largest percent increase since Dec. 13, 2023, when it rose 13.23% --Currently up three consecutive days; up 6.31% over this period --Best three day stretch since the three days ending Dec. 15, 2023, when it rose 14.8% --Up 15.26% year-to-date --Up 40.24% from 52 weeks ago (June 5, 2023), when it closed at $334.42 --Would be a new 52-week closing high --Up 44.46% from its 52-week closing low of $324.65 on June 7, 2023 --Traded as high as $468.98; new all-time intraday high (Based on available data back to July 24, 1991) --Up 3% at today's intraday high --Eighth best performer in the S&P 500 today --Fifth best performer in the Nasdaq 100 today All data as of 11:19:10 AM ET Source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires June 03, 2024 11:21 ET (15:21 GMT)

04:08 AM EDT, 05/31/2024 (MT Newswires) -- Charles F Wagner Jr, Executive Vice President & Chief Financial Officer, on May 28, 2024, sold 3,250 shares in Vertex Pharmaceuticals (VRTX) for $1,478,068. Following the Form 4 filing with the SEC, Wagner ...